Raparia C, Quach TD, Zeumer-Spataro L, Choi SC, et al. Combination CTLA4Ig and Anti-CD40 Ligand Treatment Modifies T and B Cell Metabolic Profiles and Promotes B Cell Receptor Remodeling in a Mouse Model of Systemic Lupus Erythematosus. J Immunol 2023 Jan 16:ji2100792. doi: 10.4049/jimmunol.2100792.
PMID: 36645445